Mayo Clinic Talks Episode 66: Treating Musculoskeletal Pain: The Role of Platelet-Rich Plasma Injections and Stem Cell Therapy
Mayo Clinic Talks
Jacob L. Sellon, M.D.
|Dr. Jacob Sellon discusses advances in treatment of musculoskeletal pain and osteoarthritis, covering common questions about platelet-rich plasma and stem cell injections. Do they work? What’s the efficacy demonstrated in literature so far? What are the benefits and risks we need to discuss with our patients? What is FDA compliant versus FDA approved treatment and how does this influence insurance coverage and care management? Where does regenerative medicine research need to go?|
This course is intended for primary care providers: physicians, nurse practitioners, and physician assistants
Upon completion of the Mayo Clinic Talks Podcast course, learners should be able to:
- Describe the current treatment recommendations for patients with hyperlipidemia.
- List the various categories of hypertension.
- Describe the current pharmacologic treatment available for patients with osteoporosis.
Participation in this Mayo Clinic online course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Attendance